5 Results for "

pyrrolidinedione

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "pyrrolidinedione" in MCE Product Catalog:

9
9 Cited Publications
Cat. No.: HY-Y0623
CAS No.: 6066-82-6
Synonyms: HOSu; 1-Hydroxy-2,5-pyrrolidinedione
N-Hydroxysuccinimide (HOSu; 1-Hydroxy-2,5-pyrrolidinedione) is a covalent crosslinker commonly used in bioconjugation technology with a primary amine group. N-Hydroxysuccinimide reacts with amino groups (-NH2) to form a stable amide bond, which can modify amino-containing biomolecules. N-Hydroxysuccinimide can be used, for example, for protein labeling with fluorescent dyes and enzymes, surface activation of chromatography supports, microbeads, nanoparticles and microarray slides, and chemical synthesis of peptides. N-Hydroxysuccinimide has a wide range of applications in biomaterial synthesis (such as collagen, chitosan crosslinking), drug delivery systems (such as hydrogel preparation) and tissue engineering .
loading...
    loading...
Cat. No.: HY-Y0775
CAS No.: 128-08-5
1-Bromo-2,5-pyrrolidinedione is a collagen protein ligand in docking experiments. 1-Bromo-2,5-pyrrolidinedione can be used to study wound healing-related diseases .
loading...
    loading...
Cat. No.: HY-Y0775R
CAS No.: 128-08-5
1-Bromo-2,5-pyrrolidinedione (Standard) is the analytical standard of 1-Bromo-2,5-pyrrolidinedione (HY-Y0775). This product is intended for research and analytical applications. 1-Bromo-2,5-pyrrolidinedione is a collagen protein ligand in docking experiments. 1-Bromo-2,5-pyrrolidinedione can be used to study wound healing-related diseases .
loading...
    loading...
Cat. No.: HY-151875
CAS No.: 2866186-38-9
Target:  

Bacterial

Research Areas:  

Infection Inflammation/Immunology

MurA-IN-3 is a reversible pyrrolidinedione-based MurA inhibitor. MurA-IN-3 has inhibitory activity for MurA with an IC50 value of 4.5 μM. MurA-IN-3 also has antibacterial activity .
loading...
    loading...
Cat. No.: HY-189264
Target:  

Drug Derivative

Research Areas:  

Cancer

Anticancer agent-362 is a chimeric pyrrolidinedione-pyrrolidine-phthalazine-triazole (PPPT) heterocyclic derivative with antitumor activity. Anticancer agent-362 exhibits antiproliferative activity against breast adenocarcinoma and osteosarcoma cancer cell lines, with low toxicity to normal fibroblasts. Anticancer agent-362 is predicted to be a multi-target ligand that binds to the active sites of VEGFR-2, PARP-1, and others. Anticancer agent-362 can be used in research related to breast adenocarcinoma and osteosarcoma .
loading...
    loading...